QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)

Shockwave Medical (SWAV) Competitors

$270.53
+11.91 (+4.61%)
(As of 02/22/2024 ET)

SWAV vs. PEN, GMED, TFX, PODD, INSP, MMSI, GKOS, HAE, IART, and AXNX

Should you be buying Shockwave Medical stock or one of its competitors? The main competitors of Shockwave Medical include Penumbra (PEN), Globus Medical (GMED), Teleflex (TFX), Insulet (PODD), Inspire Medical Systems (INSP), Merit Medical Systems (MMSI), Glaukos (GKOS), Haemonetics (HAE), Integra LifeSciences (IART), and Axonics (AXNX). These companies are all part of the "surgical & medical instruments" industry.

Shockwave Medical vs.

Penumbra (NYSE:PEN) and Shockwave Medical (NASDAQ:SWAV) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Penumbra presently has a consensus price target of $307.25, indicating a potential upside of 18.27%. Shockwave Medical has a consensus price target of $259.38, indicating a potential downside of 3.46%. Given Shockwave Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Penumbra is more favorable than Shockwave Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Penumbra
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80
Shockwave Medical
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75

88.2% of Penumbra shares are owned by institutional investors. Comparatively, 87.4% of Shockwave Medical shares are owned by institutional investors. 5.3% of Penumbra shares are owned by company insiders. Comparatively, 3.4% of Shockwave Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Shockwave Medical has a net margin of 20.17% compared to Shockwave Medical's net margin of 4.08%. Penumbra's return on equity of 23.97% beat Shockwave Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Penumbra4.08% 5.54% 4.10%
Shockwave Medical 20.17%23.97%12.78%

Penumbra received 653 more outperform votes than Shockwave Medical when rated by MarketBeat users. Likewise, 80.43% of users gave Penumbra an outperform vote while only 57.39% of users gave Shockwave Medical an outperform vote.

CompanyUnderperformOutperform
PenumbraOutperform Votes
785
80.43%
Underperform Votes
191
19.57%
Shockwave MedicalOutperform Votes
132
57.39%
Underperform Votes
98
42.61%

In the previous week, Shockwave Medical had 26 more articles in the media than Penumbra. MarketBeat recorded 41 mentions for Shockwave Medical and 15 mentions for Penumbra. Penumbra's average media sentiment score of 0.67 beat Shockwave Medical's score of 0.66 indicating that Shockwave Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Penumbra
5 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Shockwave Medical
15 Very Positive mention(s)
5 Positive mention(s)
13 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Shockwave Medical has lower revenue, but higher earnings than Penumbra. Shockwave Medical is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Penumbra$847.13M12.01-$2M$1.03255.85
Shockwave Medical$730.23M13.58$147.28M$3.8769.42

Penumbra has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, Shockwave Medical has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500.

Summary

Penumbra and Shockwave Medical tied by winning 9 of the 18 factors compared between the two stocks.


Get Shockwave Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SWAV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SWAV vs. The Competition

MetricShockwave MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$9.91B$3.85B$5.13B$7.49B
Dividend YieldN/A2.05%2.90%3.86%
P/E Ratio69.4215.1296.4014.93
Price / Sales13.5825.252,974.7759.76
Price / Cash42.3131.2189.2653.30
Price / Book14.834.024.314.61
Net Income$147.28M$20.55M$112.41M$207.21M
7 Day Performance13.69%-0.83%0.91%-0.65%
1 Month Performance23.49%8.38%6.28%3.57%
1 Year Performance40.00%2.45%8.13%4.09%

Shockwave Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PEN
Penumbra
3.8487 of 5 stars
$268.61
-0.7%
$307.25
+14.4%
-0.1%$10.37B$847.13M260.793,900News Coverage
GMED
Globus Medical
4.6237 of 5 stars
$54.17
+0.7%
$66.50
+22.8%
-7.0%$7.46B$759.12M34.952,600Earnings Report
Analyst Report
Analyst Revision
News Coverage
TFX
Teleflex
4.4286 of 5 stars
$250.95
0.0%
$269.30
+7.3%
+4.0%$11.79B$2.79B29.4215,500Earnings Report
Dividend Announcement
News Coverage
Gap Down
PODD
Insulet
4.8405 of 5 stars
$192.21
+0.6%
$250.40
+30.3%
-34.1%$13.42B$1.31B112.402,600News Coverage
Positive News
INSP
Inspire Medical Systems
4.489 of 5 stars
$191.71
-0.6%
$272.92
+42.4%
-30.3%$5.67B$624.80M-259.071,011Positive News
Gap Down
MMSI
Merit Medical Systems
4.8592 of 5 stars
$79.95
+0.6%
$91.13
+14.0%
+14.1%$4.62B$1.15B46.216,846Upcoming Earnings
Analyst Downgrade
GKOS
Glaukos
3.604 of 5 stars
$92.18
-0.5%
$89.50
-2.9%
+84.8%$4.50B$282.86M-34.27783Earnings Report
Analyst Upgrade
News Coverage
Gap Up
HAE
Haemonetics
4.4476 of 5 stars
$71.41
-1.3%
$104.67
+46.6%
-9.0%$3.67B$1.27B29.033,034
IART
Integra LifeSciences
3.191 of 5 stars
$45.20
+0.4%
$46.22
+2.3%
-21.1%$3.53B$1.56B37.363,722Upcoming Earnings
News Coverage
Gap Down
AXNX
Axonics
3.4476 of 5 stars
$67.96
+0.3%
$71.09
+4.6%
+18.8%$3.44B$273.70M-271.84610Positive News

Related Companies and Tools

This page (NASDAQ:SWAV) was last updated on 2/22/2024 by MarketBeat.com Staff